Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Allergology International · 2025
DOI: 10.1016/j.alit.2025.02.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergology International, 2025. Verfasst von Masato Tamari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address: tamari…. Hauptthemen laut MEDLINE: Skin, Neuroimmunomodulation, Inflammation, Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mishima Kaiun Memorial Foundation, National Center for Child Health and Development, Japanese Society of Allergology.
Abstract (Originalsprache)
Type 2 inflammation has a major role in barrier tissues such as the skin and airways and underlies common conditions including atopic dermatitis (AD) and asthma. Cytokines including interleukin 4 (IL-4), IL-5, and IL-13 are key immune signatures of type 2 inflammation and are the targets of multiple specific therapeutics for allergic diseases. Despite shared core immune mechanisms, the distinct structures and functions of the skin and airways lead to unique therapeutic responses. It is increasingly recognized that the nervous system has a major role in sensing and directing inflammatory processes. Indeed, crosstalk between type 2 immune activation and somatosensory functions mediates tissue-specific signatures such as itching in the skin. However, neuroimmune interactions are shaped by distinct neuronal and immune landscapes, and differ between the skin and airways. In the skin, dorsal root ganglia-derived neurons mediate pruritus via type 2 cytokines and neurogenic inflammation by mast cell or basophil activation. Conversely, vagal ganglia-derived neurons regulate airway immune responses by releasing neuropeptides/neurotransmitters such as calcitonin gene-related peptides, neuromedin U, acetylcholine, and noradrenaline. Sensory neuron-derived vasoactive intestinal peptide forms a feedback loop with IL-5, amplifying eosinophilic inflammation in the airways, a mechanism that is absent in the skin. These differences influence the efficacy of cytokine-targeted therapies. For instance, IL-4/IL-13-targeted therapies like dupilumab demonstrate efficacy in AD and allergic airway diseases, whereas IL-5-targeted therapies are effective in eosinophilic asthma but not AD. Understanding these neuroimmune interactions underscores the need for tailored therapeutic approaches to address allergic diseases where barrier tissues are involved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address: tamari-m@ncchd.go.jp.
- Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, USA. Electronic address: averheul@wustl.edu.
Förderung
- Mishima Kaiun Memorial Foundation
- National Center for Child Health and Development
- Japanese Society of Allergology
- Japan Society for the Promotion of Science
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Tamari, M., & Ver Heul, A. M. (2025). Neuroimmune mechanisms of type 2 inflammation in the skin and lung. Allergology International. https://doi.org/10.1016/j.alit.2025.02.001
Vancouver
Tamari M, Ver Heul AM. Neuroimmune mechanisms of type 2 inflammation in the skin and lung. Allergology International. 2025. doi:10.1016/j.alit.2025.02.001
BibTeX
@article{Tamari2025,
author = {Tamari, Masato and Ver Heul, Aaron M},
title = {Neuroimmune mechanisms of type 2 inflammation in the skin and lung},
journal = {Allergology International},
year = {2025},
doi = {10.1016/j.alit.2025.02.001}
}
EUVIMED